Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keverprazan versus esomeprazole for non-erosive reflux disease
ChiCTR2400087867Phase 4Not yet recruiting
- Sponsor
- Eighth Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of keverprazan and esomeprazole in Non-erosive Gastroesophageal Reflux Disease (NERD) (3 arms), sponsored by Eighth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Complete response rate. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
keverprazanesomeprazole
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on ChiCTR2400087867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087867.